---
document_datetime: 2023-09-21 21:09:35
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cuprymina-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: cuprymina-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.2435025
conversion_datetime: 2025-12-30 10:26:17.419033
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cuprymina

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                                                                             |
|----------------------|-----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0023               | Renewal of the marketing authorisation. | 22/04/2022                          | 21/06/2022                                  | SmPC, Annex II and PL            | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Cuprymina in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. PL section 1 should be revised in line with the SPC section |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                             |            |            |                        | 4.1, as follows ('and authorised being added text): 'Cuprymina is used for radiolabelling, a technique in which a substance is tagged (radiolabelled) with a radioactive compound. Cuprymina is used to label certain medicines that have been specially developed and authorised for use with the active substance copper (64Cu) chloride'.   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10040 /201908 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                                                                                                        | 12/03/2020 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                              |
| T/0022              | Transfer of Marketing Authorisation                                                                                                                                         | 31/01/2020 | 28/02/2020 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                |
| IB/0020             | B.II.z - Quality change - Finished product - Other variation                                                                                                                | 13/11/2019 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                |
| IB/0019/G           | This was an application for a group of variations. B.I.z - Quality change - Active substance - Other variation B.II.z - Quality change - Finished product - Other variation | 09/08/2019 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                |
| IA/0018             | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                | 14/05/2019 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                |
| PSUSA/10040 /201808 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                                                                                                        | 14/03/2019 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                              |
| IB/0016             | B.II.e.6.z - Change in any part of the (primary)                                                                                                                            | 30/04/2018 | 17/04/2019 | SmPC,                  |                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|                     | packaging material not in contact with the finished product formulation - Other variation    |            |            | Labelling and PL                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|---------------------|----------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10040 /201708 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                         | 08/03/2018 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| R/0014              | Renewal of the marketing authorisation.                                                      | 18/05/2017 | 19/07/2017 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Cuprymina in the approved indication remains favourable, but recommended that one additional five-year renewal be required based on the following pharmacovigilance grounds: The very limited exposure to Cuprymina (cumulative total sales of 152 vials in the EU) is considered to be grounds for requiring an additional five-year renewal. This would enable the generation of further data which would provide assurance that any risks for this product have been detected and adequately characterised in the post- |
| PSUSA/10040 /201608 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                         | 09/03/2017 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| PSUSA/10040 /201602 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                         | 02/09/2016 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| PSUSA/10040 /201508 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                         | 17/03/2016 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| IAIN/0011           | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer | 17/02/2016 | 16/03/2016 | Annex II and                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

|                     | responsible for batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            | PL                               |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IAIN/0010/G         | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location | 17/02/2016 | 16/03/2016 | SmPC, Labelling and PL           |                                   |
| IB/0008             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                  | 16/10/2015 | 16/03/2016 | SmPC and Labelling               |                                   |
| PSUSA/10040 /201502 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 10/09/2015 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0007/G           | This was an application for a group of variations. B.I.a.1.a, B.II.b.1.a, B.II.b.1.f, B.II.b.2.c.2 - To add SPARKLE Srl, Contrada Cal√≤, snc 73042 Casarano (LE) Italy as a site responsible the manufacture/QC of the intermediate/active substance, primary and secondary packaging, batch release including batch control/testing and manufacture of the finished                                                                                                                                                                        | 24/07/2015 | 16/03/2016 | SmPC, Annex II, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| product. B.I.a.2.z, B.II.b.3.a - Minor change in the manufacturing process of the active substance and finished product due to different equipment used at the SPARKLE site. Furthermore, the MAH took the opportunity to update the fax no of the MAH in the SmPC and PIL. B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                     | the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                           |            |            |                        |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IAIN/0005/G         | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH C.I.12 - Inclusion or deletion of black symbol and explanatory statements for medicinal products in the list of medicinal products that are subject to additional monitoring | 20/03/2015 | 16/03/2016 | SmPC, Labelling and PL |                                   |
| PSUSA/10040 /201408 | Periodic Safety Update EU Single assessment - copper (64Cu) chloride                                                                                                                                                                                                                                       | 12/02/2015 | n/a        |                        | PRAC Recommendation - maintenance |
| PSUV/0002           | Periodic Safety Update                                                                                                                                                                                                                                                                                     | 11/09/2014 | n/a        |                        | PRAC Recommendation - maintenance |
| IAIN/0003           | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                            | 09/07/2014 | n/a        |                        |                                   |
| PSUV/0001           | Periodic Safety Update                                                                                                                                                                                                                                                                                     | 13/06/2014 | n/a        |                        | PRAC Recommendation - maintenance |